AKR1C3 decreased CML sensitivity to Imatinib in bone marrow microenvironment via dysregulation of miR-379-5p.
Cell Signal
; 84: 110038, 2021 08.
Article
in En
| MEDLINE
| ID: mdl-33984486
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
/
MicroRNAs
/
Imatinib Mesylate
/
Aldo-Keto Reductase Family 1 Member C3
Type of study:
Diagnostic_studies
/
Prognostic_studies
Limits:
Animals
/
Humans
Language:
En
Journal:
Cell Signal
Year:
2021
Document type:
Article
Affiliation country: